Journal archive · Non-surgical and filler rhinoplasty · 2021
Nonsurgical Rhinoplasty With the Novel Hyaluronic Acid Filler VYC-25L: Results Using a Nasal Grid Approach
Bertossi D, Malchiodi L, Albanese M, Nocini R, Nocini P.
What this paper says
In 61 patients treated with the filler VYC-25L using a grid based injection protocol, correction was rated 9 or 10 out of 10 at two weeks, results held at 6 months, and bruising affected a quarter of patients.
Overview
Nonsurgical reshaping of the nose with injectable filler is increasingly common. VYC-25L is a hyaluronic acid product with the firmness and cohesiveness the authors say a nasal filler requires. This retrospective single centre analysis assessed its safety and effectiveness in adults treated between February and April 2019 using a previously published grid system that dictates how much filler goes where and in what order.
Sections of note
- Retrospective, single centre analysis of 61 patients; mean age 32 years, 45 female, 74 percent.
- Procedures included correcting inadequate projection, deep glabella treatment, correcting a nasal hump, and adjusting the nasolabial angle and columella.
- Follow up ran 6 to 9 months.
- At 2 weeks, independent evaluation scored every patient 9 or 10 on a 10 point visual analog scale for defect correction.
- Fifty nine of 61 patients, 97 percent, rated their own correction as adequate.
- Results were stable at the 3 month and 6 month visits.
- Complications were bruising in 15 patients, 25 percent, asymmetry in 2, 3 percent, and hematoma in 1, 2 percent, all resolving rapidly.
- There were no cases of infection, visible bumps or skin death.
What it means for a patient
- Filler can raise the bridge and change the angle between nose and lip without surgery.
- Bruising was common; the serious complications feared with nasal filler did not occur here.
- Sixty one patients at one centre is too small to detect rare events such as blocked blood vessels.
- Follow up stopped at 6 to 9 months, so longer duration is not reported.
Why this paper matters
Injectable nose reshaping has spread faster than the safety data behind it, and the nose is the facial area where filler complications are most severe. This study reports one product used under a defined protocol. Rare vascular complications and results past a year remain unmeasured.
Terms
- Hyaluronic acid filler: an injectable gel that adds volume and can be dissolved if needed.
- G prime: a measure of a filler's firmness and resistance to deformation.
- Glabella: the flat area between the eyebrows.
- Nasolabial angle: the angle formed between the base of the nose and the upper lip.
- Visual analog scale: a rating along a line, here from 0 to 10.
Summary written by rhinoplasty.cc from the abstract, 2026-09-09; not medical advice. The authors' own abstract follows.
From the abstract
“Nonsurgical aesthetic treatment of the nose is becoming increasingly popular. VYC-25L is a novel hyaluronic acid product with the high G' and cohesivity required of a nasal filler. Objectives: The authors sought to assess the safety and efficacy of VYC-25L for treatment of the nose utilizing a previously published,…”
Excerpt; the full abstract is on PubMed.
Citation
Start here
What the rhinoplasty literature says on this paper's topic, cited line by line to PubMed.
Related papers
Same topic, 2021.
- APS Invited Discussion on: "Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic Acid"Gubisch W, Hacker S2021PMID 33782723
- APS Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic AcidRamos HHA, Freire L, Cavallieri F et al.2021PMID 33616714Summary
- APS Non-Surgical Rhinoplasty: The Ascending Technique and a 14-Year Retrospective Study of 2130 CasesKassir R, Venkataram A, Malek A et al.2021PMID 33216177Summary
- APS Patient Satisfaction After Non-surgical Rhinoplasty Using Hyaluronic Acid: A Literature ReviewRadulesco T, De Bonnecaze G, Penicaud M et al.2021PMID 33660013Summary
- FPSAM Commentary on "Nonsurgical Rhinoplasty Using Injectable Fillers: A Safety Review of 2488 Procedures" by Rivkin: Cannula Use During Dermal Filler InjectionSulyman O, Dayan S2021PMID 33270498
- FPSAM 2021PMID 33270519Summary
- PRS The "3P" Maneuver: A Simple Technique to Improve Vascular Safety in Nonsurgical RhinoplastySegreto F, Marangi GF, Caldaria E et al.2021PMID 33027204
- PRS The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 TreatmentsBarone M, Cogliandro A, Persichetti P2021PMID 34468422